Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
| Image |  |
|---|---|
| Description | scientific article published on 13 October 2017 |
| Author/s |
author: Kenji Tamura Toshihiko Doi Yasuhiro Fujiwara Chikako Shimizu Yusuke Ogitani Tatsunori Shimoi Kan Yonemori Akihiko Shimomura |
| Publication date | October 13, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |